2002
DOI: 10.1067/mai.2002.123535
|View full text |Cite
|
Sign up to set email alerts
|

Reduced soluble CD14 levels in amniotic fluid and breast milk are associated with the subsequent development of atopy, eczema, or both

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
126
4

Year Published

2005
2005
2015
2015

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 141 publications
(137 citation statements)
references
References 30 publications
7
126
4
Order By: Relevance
“…43,44 Breast milk is thought to play an important role in the development of oral tolerance because there are a number of immunologic factors in breast milk, particularly transforming growth factor-b, which has an positive association with infant wheeze 31 ; interleukin-12, which promotes Th-1 cytokine mileau 32 ; and soluble CD14, whose levels in breast milk have been shown to be negatively associated with eczema at 6 months of age. 33 In the current study, it may be allergen-specific immunoglobulins in the mother's milk that are promoting tolerogenic mechanisms, and this theory is supported by the fact that there was no benefit of overlap seen with "any foods." It was not possible to determine if there was a similar association for other allergenic food because there were insufficient numbers of infants consuming these foods while still being breastfed.…”
Section: Discussionsupporting
confidence: 51%
See 1 more Smart Citation
“…43,44 Breast milk is thought to play an important role in the development of oral tolerance because there are a number of immunologic factors in breast milk, particularly transforming growth factor-b, which has an positive association with infant wheeze 31 ; interleukin-12, which promotes Th-1 cytokine mileau 32 ; and soluble CD14, whose levels in breast milk have been shown to be negatively associated with eczema at 6 months of age. 33 In the current study, it may be allergen-specific immunoglobulins in the mother's milk that are promoting tolerogenic mechanisms, and this theory is supported by the fact that there was no benefit of overlap seen with "any foods." It was not possible to determine if there was a similar association for other allergenic food because there were insufficient numbers of infants consuming these foods while still being breastfed.…”
Section: Discussionsupporting
confidence: 51%
“…One of the perceived benefits of breastfeeding is the reduced risk of allergy due to the presence of a number of immunomodulatory factors in breast milk. [31][32][33] However, the evidence that breastfeeding prevents allergies is contradictory, with some reviews showing a benefit while others did not. [34][35][36][37][38] These findings may be due to variations in breast milk composition, differences in maternal diet, [39][40][41][42] differences in specific infant-feeding practices, or a lack of precision in the way infant feeding has been measured.…”
Section: Discussionmentioning
confidence: 99%
“…Children having atopic symptoms and IgE sensitization at age 4 y had received colostrum with a significantly lower concentration of sCD14 than had those without symptoms and IgE sensitization, a difference present in groups with long breast-feeding and among those without family atopy, irrespective of length of breast-feeding. Jones and co-workers (27) found that infants with eczema had received at age 3 mo breast milk with lower sCD14 than did those without eczema and also showed lower amniotic fluid CD14 levels to be associated with later atopy. SCD14 is a co-receptor with a toll-like receptor 4 for lipopolysaccharide from Gram-negative bacteria needed for CD14-negative cells, such as intestinal epithelial and dendritic cells to respond to these products (28).…”
Section: Discussionmentioning
confidence: 99%
“…28 In breast fed children, low levels of soluble CD14 in breast milk had been associated with an increased risk for AD and asthma. 29,30 These defects in the pattern recognition receptors, which are the first line of defense in the innate immune system reduce the ability of AD patients to recognize cutaneous microbial pathogens resulting in an increase in their incidence of bacterial and viral infections.…”
Section: The Innate Immune Systemmentioning
confidence: 99%